Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance Today
The Dangerous Drugs Act 2000 (Act 41 of 2000) defines "gandia" as all parts of the Cannabis sativa or indica plant, which captures viable seeds, and prohibits their sale, possession and cultivation. A November 2022 amendment allows medical cannabis only through authorisation of the Ministry of Health and Wellness, not private seed purchase or home growing. Industrial hemp has been the subject of National Agency for Drug Control policy consultations, but no operational hemp seed licensing regime has been verified, so that pathway remains unclear.
